Deep Vein Thrombosis

Author(s)	Dr. Anjum Abbasi, Mr. Devender, Ms. Ritu
Country	India
Abstract	Deep vein thrombosis (DVT) is a major preventable cause of morbidity and mortality worldwide. Venous thromboembolism (VTE), which includes DVT and pulmonary embolism (PE), affects an estimated 1 per 1,000 people and contributes to 60,000–100,000 deaths annually. Normal blood physiology hinges on a delicate balance between pro- and anti-coagulant factors. Virchow’s Triad distills the multitude of risk factors for DVT into three basic elements favoring thrombus formation: venous stasis, vascular injury, and hypercoagulability. Clinical, biochemical, and radiological tests are used to increase the sensitivity and specificity for diagnosing DVT.
Keywords	Deep vein thrombosis (DVT), vitamin K-antagonists (VKAs), warfarin, direct oral anticoagulants (DOACs), anticoagulants
Field	Medical / Pharmacy
Published In	Volume 6, Issue 4, July-August 2024
Published On	2024-08-27
Cite This	Deep Vein Thrombosis - Dr. Anjum Abbasi, Mr. Devender, Ms. Ritu - IJFMR Volume 6, Issue 4, July-August 2024. DOI 10.36948/ijfmr.2024.v06i04.26647
DOI	https://doi.org/10.36948/ijfmr.2024.v06i04.26647
Short DOI	https://doi.org/gt8gwt

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research